Welcome. If you're a registered user, please log-in. If not, please sign-up.

Europe's Premier Biological Forum for Improving the Biological Production, Quality and Efficiency of Biomanufacturing while Reducing Costs and Development Timelines for Antibodies and Non-Antibodies

1 Event 4 Streams

CONFERENCE 1:  Upstream and Analytical Support for Antibodies and Non Antibodies

CONFERENCE 2:   Downstream and Analytical Support for Antibodies and Non Antibodies

CONFERENCE 3:   QbD and Process Validation for Product Life Cycle

CONFERENCE 4:   Novel Approaches; Single- Use, Flexible Operations and Modular Facility

What did delegates think of BioProduction 2011?

This conference offered a very good overview about the current state of the art processes and an outlook to the up-coming future (Roche Glycart)

Interesting and diversified (Aktehom)

There was something for everybody who works in the Bioprocessing Industry (Sandoz) 

This is the most wonderful conference I have ever seen, well organised and relevant topics (Dr Reddys)

I enjoyed the breadth and depth of current technical and regulatory issues (BioProcess Tech Consultants)

Join us in Berlin to Celebrate our 10th Anniversary of BioProduction

4 Tailored Streams – 1 Data-driven Event

 

Focusing on upstream and downstream optimisation, scale-up, disposables, QbD, biosimilars, characterisation, analytics, formulation...plus much, much more

A dedicated track on Biosimilars: Looking at manufacturing, analytical and regulatory issuese our  

Celebrate our 10th Anniversary with Dr Ray Field at Medimmune, Professor Roy Jefferis at University of and Professor John Birch former Lonza who all spoke at our first BioProduction event in 2002. Hear their views on how far the industry has come and what the future may hold. 

Speakers Confirmed for 2012

Please Download Brochure for Full List of Speakers

Speakers Confirmed for 2012

Dr Michiel E. Ultee Chief Scientific Officer Laureate Biopharmaceutical Services, Inc., USA

Professor Roy Jefferis Division of Immunity and
Infection
University of Birmingham, UK

Dr Gert Mølgaard VP, Strategic Development NNE Pharmaplan, Denmark

Dr Ray Field Director, Cell Sciences and CMC Team Leader MedImmune, UK


Free Download from 2011 event

1. Download Ellen McCormick's Fantastically Well Received Presentation on The Integration Challenges faced by Pfizer at BioProduction 2011 - Day One Plenary


..

Corporate Sponsors

..
..
..
..

Associate Sponsor

..
..
..
..

Spotlight Sponsors

..
..

Exhibitors - Book Now

..
..

Media Partners

..
..
..

Choice of 8 Practical, Expert-Led Workshops and a Site Visit

Pre-Conference Workshops – Tuesday 23 October 2012

Site Visit: TU Berlin and Medical Biotechnology

Practical Technology Transfer for Biopharmaceuticals

Analytical Tools Helping to Develop and Solve Issues with Formulation

Biopharmaceutical Fundamentals

Mixed Mode Chromatography Strategies for Biomolecule Production

Post-Conference Workshops – Friday 26 October 2012

Implementation of QbD for Biopharmaceuticals - the Pain and the Gain

Comparability: Developing Strategies for Scaling Up, Tech Transfer and

Other Process Changes

Understanding Aggregation and Devising Prevention Strategies

Expression Systems for Antibodies and Their Fragments

Further details and sample documentation

Over 300 Bioprofessionals Attended in 2011

Abbott Abbott Biologics Manufacturing Abbott BioResearch Centre Abbott Laboratories Acceleron Pharma Advanced Scientifics Aegis Analytical Corporation Aktehom AllpaQ Packaging Limited
Alnylam Biotherapeutics Amgen Arnold and Porter LLP AS Tec Chemical Ltd Asahi Kasei Bioprocess Europe Atoll GmbH Avacta Group Plc Avantor Performance Materials
BAC BV Baxter AG Bayer Technology Services GmbH BD Biosciences Bioingenium Biopharm Services BioProcess Technology Consultants Bioproducts Laboratory
Biortus Biosciences Bioscale, Inc Boehringer Ingelheim Pharma GmbH & Co KG Brockmeyer BioPharma Caliper Life Sciences Cellectis Bioresearch CEVEC Pharmaceuticals GmbH CMC Biologics
Dr Reddys DSM Biologics Eppendorf ERA Consulting Group ESBAtech AG ETH Zurich FDA Finesse Solutions AG Fraunhofer ITEM Fujifilm Diosynth
Biotechnologies GE Healthcare Life Sciences Genmab Genentech Genzyme GlaxoSmithKline H Lundbeck AS Horizon Discovery Ltd Hyde Engineering & Consulting
ImmunoGen Inc iQur Janssen Biologics JSR MICRO Karlsruher Institut für Technologie (KIT) Leiden University Medical Center Lek Pharmaceuticals LEWA GmbH
Life Technologies Inc Lonza Lonza Biologics Lonza Verviers Ludger Media Omics MedImmune Merck Merck Millipore Merck Serono
Merus BV MHRA MorphoSys AG M-Scan GmbH MSD NNE Pharmaplan Novartis NovImmune SA Octapharma PAA Laboratories
Pall Life Sciences Parexel Parker domnick hunter Parker Hannifin GmbH Pfizer Pieris AG Pneumatic Scale Angelus ProBioGen AG RD Biotech Rentschler Biotechnologie
GmbH Repligen Corporation Rise n Shine Roche Diagnostics Roche Glycart AG Sandoz Sanofi Aventis Deutschland GmbH Sanofi Chimie Sanofi Pasteur
Sartorius Stedim Biotech GmbH Sartorius Stedim UK Ltd SCIL Proteins GmbH SGS M Scan Spinnovation Analytical Sterne Kessler Goldstein Fox P.L.L.C Stratophase Ltd Suppremol
Sutro Biopharma Swiss Federal Institute of Technology Lausanne and ExcellGene SA Symphogen A/S Synthon B.V Therapeomic Inc Thermo Fisher Scientific Tiselab s.l. Toxikon Europe
Trion Pharma GmbH UCB Celltech UCB Farchim SA Umetrics University of Geneva University of Natural resources and Applied Life Sciences UV Cap GmbH & Co KG VIB Switch Lab
VICAM, A Waters Business Water

LinkedIN

BioProcessing Professionals Europe - 200+ members

Discussing the latest updates and downloads

 

Poll

Is QbD just a current buzz word or a fundamental change in process strategy?

 
 


 

Latest tweets from @Bioproduction

 

twitter Join BioProduction on Twitter

Feeds
rss
Like
Share
twitterfacebooklinkedinemail

Corporate Sponsors

Corporate Sponsors Corporate Sponsors

Bookmark and Share